The study highlights that the incidence of kidney stones in IBD has increased. The analysis revealed that the location of the disease and the use of certain medications, such as ciprofloxacin, corticosteroids, immunomodulators, and metronidazole, are important risk factors for nephrolithiasis. Research suggests that the prevalence of kidney stones in this population is substantial and that regular screening is crucial for effective clinical management.
